8PM ET: https://globalmeet.webcasts.com/starthere.jsp?ei=1719596&tp_key=839d0810ff
Program Description
The pathogenesis of anemia in patients with cancer is complex and multifactorial. Evaluation and treatment of patients with anemia can be challenging, especially for patients with complicated cancers, including solid tumors or hematologic malignancies. Traditional therapies used to manage anemia in patients without cancer do not have the same efficacy in patients with cancer, and understanding evidence-based strategies to overcome these challenges is necessary for the health and well-being of patients with cancer. The pharmacist’s role in understanding IDA in patients with cancer is crucial, as it involves managing the underlying etiology, replenishing iron stores, and improving quality of life. This webinar will examine recommendations for identifying IDA and managing iron replacement therapies following evidence-based treatment pathways. This webinar is part of the Iron Deficiency Anemia Webinar series.
Target audience: Ambulatory care pharmacist, oncology pharmacist, community pharmacist, health system pharmacist
Type of activity: Application
Release date: June 18, 2025
Expiration date: August 18, 2025
Time to complete activity: 1.0 hours
Learner level: Introductory
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify treatment-induced causes of anemia in patients with cancer.
- Provide iron replacement recommendations for patients with cancer.
- Construct care plans for oncology patients with iron deficiency anemia based on treatment regimen.
TBD
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number TBD. The activity is available for CE credit through TBD.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
TBD
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Liza Patel, PharmD, RPh; Victoria Chirdo; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms